VagalA, Meganathan K, Kleindorfer DO,Adeoye O, Hornung R, Khatri P. Increasing use of computed tomographic perfusion and computed tomo- graphic angiograms in acute ischemic stroke from 2006 to 2010. Stroke. 63. Demaerschalk BM, Yip TR. Economic benefit of increasing uti- lization of intravenous tissue plasminogen activator for acute is- chemic stroke in the United States. Stroke. 2005;36:2500 2503. doi: 64. Demaerschalk BM, Durocher DL. How diagnosis-related group 559 will change the US Medicare cost reimbursement ratio for stroke centers. 65. Penaloza-Ramos MC, Sheppard JP, Jowett S, Barton P, Mant J, Quinn T, Mellor RM, Sims D, Sandler D, et al; on behalf of the Birmingham and Black Country Collaborations for Leadership in Applied Health Research and Care Investigators. Cost-effectiveness of optimizing acute stroke care services for thrombolysis. Stroke. 2014;45:553 562. doi: 66. Tan Tanny SP, Busija L, Liew D, Teo S, Davis SM, Yan B. Cost- effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center. Stroke. 2013;44:2269 2274. 67. Health Quality Ontario. Mechanical thrombectomy in patients with acute ischemic stroke: a health technology assessment. Ont Health Technol Assess Ser. 2016;16:1 79. 68. Ganesalingam J, Pizzo E, Morris S, Sunderland T, Ames D, Lobotesis K. Cost-utility analysis of mechanical thrombectomy using stent retrievers in acute ischemic stroke. Stroke. 2015;46:2591 2598. 68a. Tong X, Wiltz JL, George MG, Odom EC, Coleman King SM, Chang T, XiaopingY, Paul Coverdell National Acute Stroke Program Team, Meritt RK. A decade of improvement in door-to-needle time among acute is- chemic stroke patients, 2008 to 2017. Circ Cardiovasc Qual Outcomes. 68b. Wiedmann S, Heuschmann PU, Hillmann S, Busse O, Wietholter H, Walter GM, Seidel G, Misselwitz B, Janssen A, Berger K, et al; German Stroke Registers Study Group. 